EverlyWell is a provider of at-home health care tests. The company makes lab testing easy and convenient with at-home collection and digital results in days.
EverlyWell is building the definitive technology-enabled health care platform that consumers deserve and have already come to expect in other areas of their lives.
EverlyWell was founded in 2015 by Julia Cheek and is based in Austin, Texas.
EverlyWell offers a range of exams in categories like general wellness, men’s health, women’s health, energy and weight, sexual health, and genomics.
EverlyWell's comprehensive test kits measure key biomarkers through dried blood spot, urine or saliva samples that are collected in the comfort of your home. Its food sensitivity kit tests reactions to 96 commonly found foods, while its HbA1c test checks for unhealthy blood sugar levels.
EverlyWell's kits also covers cholesterol and lipids, heart health, blood sugar levels, Omega-3 levels, chlamydia and gonorrhea, hepatitis C, HIV, syphilis, trichomoniasis, folic acid levels, Lyme disease, metabolism, thyroid, testosterone, breast milk, heavy metals, sleep and stress, and ovarian reserves.
Everlywell has also expanded availability of its products this year, with distribution in more than 10,000 retail locations across Target, Walgreens, CVS and Kroger stores across the U.S.
EverlyWell is backed by BlackRock, Goodwater Capital, Highland Capital Partners, The Chernin Group (TCG), Next Coast Ventures, Foresite Capital, HealthQuest Capital, NextGen Venture Partners and others. The company raised $75M in new financing on Jan 17, 2021. This brings EverlyWell's total funding to $330M to date. EverlyWell was valued at $1.3B after it had raised its Series D in Dec 2020.